Procedure Volume Patient Data Patient Conditions Reviews General Payments Back to Top

Home > AZ Providers

Dr. Benjamin BA Bakall, MD, PHD

(No ratings)

Specializes in: Vitreoretinal Diseases (Retina and Vitreous) and General Ophthalmology

15353 N. 91st Avenue
Peoria, AZ 85381

(602) 242-4928

Dr. Benjamin BA Bakall, MD, PHD is a retina specialist in Peoria, AZ specializing in vitreoretinal diseases (retina and vitreous) and general ophthalmology. Dr. Benjamin BA Bakall, MD, PHD is affiliated with Scottsdale Shea Medical Center, Scottsdale Osborn Medical Center, Phoenix Children's, Honor Health, ASSOCIATED RETINA CONSULTANTS LTD and DISTRICT MEDICAL GROUP INC.

Office Locations

Address:

15353 N. 91st Avenue
Peoria, AZ 85381

Address:

1750 E. Glendale Avenue
Phoenix, AZ 85020

In The News (see more mentions in the news)

“"The current OCU400 Phase 3 study is very exciting and gives hope for thousands of individuals with RP," said Benjamin Bakall, MD, PhD, Director of Clinical Research at Associated Retina...”—"Ocugen, Inc. Announces First Patient Dosed in Phase 3 liMeliGhT Clinical Trial for OCU400-First Gene Therapy in Phase 3 with a Broad Retinitis Pigmentosa Indication", KTLA 5, June 2024

“OCU410ST is a novel modifier gene therapy that provides hope to these patients," said Benjamin Bakall, MD, PhD, Director of Clinical Research at Associated Retina Consultants and Clinical Assistant...”—"Ocugen Announces Dosing Completion of Subjects with Stargardt Disease in Cohort 2 of Phase 1/2 GARDian Clinical Trial of OCU410ST-A Modifier Gene Therapy", FOX 2, May 2024

“MALVERN, Pa., April 29, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and...”—"Ocugen Announces OCU400-Modifier Gene Therapy-Phase 1/2 Data Presentation at Retinal Cell and Gene Therapy Innovation Summit 2024", KTLA 5, April 2024

doctor visit	4
eye procedures	714
injections	373

**Gender**
Male	132
Female	193

**Ethnicity**
Non-Hispanic White	314
Black	0
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	75
From 75 to 84	112
85 and over	125
Less than 65	13

Hypertension	67
High Cholesterol	50
Stroke	4
Ischemic Heart Disease	31
Depression	11
Chronic Kidney Disease	22
Asthma	4
Osteoperosis	7
Atrial Fibrilation	14
Heart Failure	19
Chronic Obstructive Pulmonary Disease	10
Diabetes	31
Dementia	7
Cancer	10

diagnostic imaging	26
doctor visit	582
eye procedures	4052
injections	1090
photocoagulation	15
ultrasound (sonogram)	26

**Gender**
Male	330
Female	389

**Ethnicity**
Non-Hispanic White	630
Black	18
Hispanic	55
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	267
From 75 to 84	218
85 and over	175
Less than 65	59

Hypertension	66
High Cholesterol	58
Stroke	5
Ischemic Heart Disease	34
Depression	15
Chronic Kidney Disease	27
Asthma	7
Osteoperosis	11
Atrial Fibrilation	16
Heart Failure	17
Chronic Obstructive Pulmonary Disease	11
Diabetes	34
Dementia	9
Cancer	11

diagnostic imaging	14
doctor visit	642
eye procedures	4231
injections	1167
ultrasound (sonogram)	14

**Gender**
Male	558
Female	692

**Ethnicity**
Non-Hispanic White	1084
Black	52
Hispanic	72
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	464
From 75 to 84	412
85 and over	284
Less than 65	90

Hypertension	67
High Cholesterol	59
Stroke	6
Ischemic Heart Disease	33
Depression	16
Chronic Kidney Disease	29
Asthma	10
Osteoperosis	10
Atrial Fibrilation	17
Heart Failure	17
Chronic Obstructive Pulmonary Disease	12
Diabetes	34
Dementia	12
Cancer	11

diagnostic imaging	20
doctor visit	523
evoked potential test	15
eye procedures	4468
injections	1251
ultrasound (sonogram)	20

**Gender**
Male	266
Female	404

**Ethnicity**
Non-Hispanic White	578
Black	21
Hispanic	52
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	256
From 75 to 84	219
85 and over	146
Less than 65	49

Hypertension	66
High Cholesterol	57
Stroke	6
Ischemic Heart Disease	34
Depression	19
Chronic Kidney Disease	33
Asthma	14
Osteoperosis	13
Atrial Fibrilation	15
Heart Failure	15
Chronic Obstructive Pulmonary Disease	12
Diabetes	32
Dementia	12
Cancer	12

diagnostic imaging	18
doctor visit	448
evoked potential test	14
eye procedures	5084
injections	1386
photocoagulation	9
ultrasound (sonogram)	18

**Gender**
Male	305
Female	416

**Ethnicity**
Non-Hispanic White	609
Black	26
Hispanic	60
Asian	13
Other	0
Native American	0

**Age**
From 65 to 74	279
From 75 to 84	246
85 and over	147
Less than 65	49

Hypertension	66
High Cholesterol	55
Stroke	6
Ischemic Heart Disease	31
Depression	17
Chronic Kidney Disease	34
Asthma	7
Osteoperosis	11
Atrial Fibrilation	14
Heart Failure	17
Chronic Obstructive Pulmonary Disease	13
Diabetes	32
Dementia	11
Cancer	9

diagnostic imaging	22
doctor visit	535
evoked potential test	13
eye procedures	5433
injections	1510
photocoagulation	10
prophylaxis (preventive treatment)	13
ultrasound (sonogram)	22

**Gender**
Male	340
Female	468

**Ethnicity**
Non-Hispanic White	694
Black	22
Hispanic	57
Asian	0
Other	17
Native American	0

**Age**
From 65 to 74	322
From 75 to 84	270
85 and over	165
Less than 65	51

Hypertension	66
High Cholesterol	62
Stroke	8
Ischemic Heart Disease	33
Depression	18
Chronic Kidney Disease	34
Asthma	8
Osteoperosis	13
Atrial Fibrilation	13
Heart Failure	16
Chronic Obstructive Pulmonary Disease	15
Diabetes	31
Dementia	9
Cancer	11

diagnostic imaging	31
doctor visit	637
evoked potential test	11
eye procedures	6890
injections	1835
photocoagulation	31
prophylaxis (preventive treatment)	14
ultrasound (sonogram)	31

**Gender**
Male	431
Female	590

**Ethnicity**
Non-Hispanic White	858
Black	34
Hispanic	74
Asian	0
Other	28
Native American	0

**Age**
From 65 to 74	403
From 75 to 84	343
85 and over	204
Less than 65	71

Hypertension	68
High Cholesterol	59
Stroke	5
Ischemic Heart Disease	32
Depression	18
Chronic Kidney Disease	37
Asthma	7
Osteoperosis	15
Atrial Fibrilation	13
Heart Failure	18
Chronic Obstructive Pulmonary Disease	13
Diabetes	29
Dementia	10
Cancer	12

diagnostic imaging	37
doctor visit	560
eye procedures	6122
injections	1834
photocoagulation	13
prophylaxis (preventive treatment)	16
ultrasound (sonogram)	37

**Gender**
Male	335
Female	516

**Ethnicity**
Non-Hispanic White	696
Black	32
Hispanic	76
Asian	0
Other	29
Native American	0

**Age**
From 65 to 74	333
From 75 to 84	282
85 and over	174
Less than 65	62

Hypertension	64
High Cholesterol	56
Stroke	5
Ischemic Heart Disease	32
Depression	20
Chronic Kidney Disease	36
Asthma	9
Osteoperosis	12
Atrial Fibrilation	11
Heart Failure	14
Chronic Obstructive Pulmonary Disease	11
Diabetes	32
Dementia	9
Cancer	12

diagnostic imaging	39
doctor visit	4224
eye procedures	10716
injections	3761
photocoagulation	13
prophylaxis (preventive treatment)	16
ultrasound (sonogram)	39

Average Medicare Procedure Volume From 2013 - 2021

Volume of procedures performed by Dr. Benjamin BA Bakall, MD, PHD for Medicare patients.

The highest averages for the top procedures that Dr. Benjamin BA Bakall, MD, PHD treated as a retina specialist in Peoria, AZ were eye procedures, injections, diagnostic imaging and ultrasound (sonogram).

diagnostic imaging	25
doctor visit	908
evoked potential test	13
eye procedures	5305
injections	1578
photocoagulation	18
prophylaxis (preventive treatment)	14
ultrasound (sonogram)	25

Average Medicare Patient Data From 2013 - 2021

Information about Medicare patients treated by Dr. Benjamin BA Bakall, MD, PHD.

**Gender**
Female	366
Male	269

**Ethnicity**
Black / African American	20
Asian / Pacific Islander	1
Non-Hispanic White	546
Native American / Alaskan Native	0
Hispanic	44
Other	7

**Age**
85 and over	142
75 to 84	210
Less than 65	44
65 to 74	239

Average of Total of Conditions of Medicare patients treated by Dr. Benjamin BA Bakall, MD, PHD From 2013 - 2021

The highest averages of the most common conditions of Medicare patients that Dr. Benjamin BA Bakall, MD, PHD treated were hypertension, high cholesterol, diabetes and ischemic heart disease.

Hypertension	53
High Cholesterol	45
Stroke	4
Ischemic Heart Disease	26
Depression	13
Chronic Kidney Disease	25
Asthma	6
Osteoporosis	9
Heart Failure	13
Chronic Obstructive Pulmonary Disease	9
Diabetes	25
Atrial Fibrillation	11
Cancer	8
Dementia	7

Education & Training

He completed residency at University of Arizona Affiliated Hospitals. He is certified by the American Board of Ophthalmology - Ophthalmology and has a state license in Arizona.

Residency: University of Arizona Affiliated Hospitals

Board Certification: American Board of Ophthalmology - Ophthalmology

Licensed In: Arizona

Affiliations & Hospitals

Dr. Benjamin BA Bakall, MD, PHD is associated with these hospitals and organizations:

Scottsdale Shea Medical Center

Scottsdale Osborn Medical Center

Phoenix Children's

Honor Health

ASSOCIATED RETINA CONSULTANTS LTD

DISTRICT MEDICAL GROUP INC

Ratings & Reviews

Dr. Benjamin BA Bakall, MD, PHD does not have any reviews yet, be the first to leave a review of Dr. Benjamin BA Bakall, MD, PHD here: Leave a Review

(No ratings)

Leave a Review

General Payments

These charts describe general payments received by Dr. Benjamin BA Bakall, MD, PHD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.

**Payments by Company**
US Retina LLC	$18,424 $18,424
Genentech, Inc.	$8,853 VABYSMO $8,502	NonCovered Product $215	LUCENTIS $137
Allergan Inc.	$6,123 OZURDEX $1,796	BOTOX $19	NATRELLE 410 IMPLANTS $10	$4,299
F. Hoffmann-La Roche AG	$4,015 $4,015
Regeneron Healthcare Solutions, Inc.	$3,278 Eylea $1,596	EYLEA aflibercept injection $1,233	EYLEA (aflibercept) Injection $423	EYLEA HD $27
Other	$13,256 ILUVIEN $1,653	LUCENTIS $1,333	Eylea $1,138	EYLEA aflibercept injection $783	EYLEA (aflibercept) Injection $662	Other $7,687

**Types of Payments**
Current or prospective ownership or investment interest	$18,146
Consulting Fee	$17,436
Food and Beverage	$14,805
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program	$2,345
Travel and Lodging	$815
Other	$403

Research Payments

Dr. Benjamin BA Bakall, MD, PHD has received 11 research payments totaling $21,452.

Ownership and Interest Payments

This table describes ownership payments received by Dr. Benjamin BA Bakall, MD, PHD.

US Retina LLC	2023	$119,773.58	Physician Covered Recipient	Membership Interest
US Retina LLC	2018	$61,212.38	Physician Covered Recipient	Shares
US Retina LLC	2022	$58,024.69	Physician Covered Recipient	Shares
US Retina LLC	2020	$58,024.69	Physician Covered Recipient	Shares
US Retina LLC	2017	$58,024.69	Physician Covered Recipient	Shares
US Retina LLC	2019	$58,024.69	Physician Covered Recipient	Shares
US Retina LLC	2016	$58,024.69	Physician Covered Recipient	Shares
US Retina LLC	2015	$58,024.69	Physician Covered Recipient	Shares
US Retina LLC	2020	$3,187.69	Physician Covered Recipient	Shares
US Retina LLC	2017	$3,187.69	Physician Covered Recipient	Shares
US Retina LLC	2019	$3,187.69	Physician Covered Recipient	Shares
US Retina LLC	2016	$1,333.60	Physician Covered Recipient	Shares

Biography

Dr. Benjamin Bakall is a specialist in general ophthalmology and vitreoretinal diseases (retina and vitreous). For his residency, Dr. Bakall trained at a hospital affiliated with the University of Arizona. Dr. Bakall is conversant in Swedish. His professional affiliations include Scottsdale Osborn Medical Center, Scottsdale Shea Medical Center, and Phoenix Children's.